Evidence map›Paper›PMID 33572979›Full record

ArticleGenes2021

Association of

Saba Abdi, Rawan A Binbaz, Abdul Khader Mohammed, Mohammed G A Ansari, Kaiser Wani, Osama E Amer, Abdullah M Alnaami, Naji Aljohani, Nasser M Al-Daghri

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Application and prospects of nanomaterials in osteoporosis treatment.International journal of pharmaceutics: X · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Genetic Variants ofGenes · 2023
    Article
  15. Review
  16. Article
  17. Association betweenFrontiers in genetics · 2022
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Saba AbdiBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Rawan A BinbazBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Abdul Khader MohammedBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Mohammed G A AnsariSharjah Institute of Medical Research, University of Sharjah, Sharjah 27272, UAE.ORCID 0000-0002-4307-7679
Kaiser WaniBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-9568-6516
Osama E AmerBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-8657-0682
Abdullah M AlnaamiBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Naji AljohaniBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Nasser M Al-DaghriBiochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-5472-1725
King Saud University · SAKing Fahd Medical City · SAUniversity of Sharjah · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Receptor activator of the nuclear factor-κB ligand (RANKL) and osteoprotegerin genes (OPG) were identified as susceptible loci for postmenopausal osteoporosis (PMO) in various ethnicities, but neither have been studied in an Arabian population. Hence, the current study aimed to fill this gap. A total of 372 postmenopausal women (174 osteoporosis (OP) and 198 control group (CTRs)) were genotyped for four SNPs: rs2277438A/G and rs9533156T/C (

Indexed as

Genetic Predisposition to DiseaseAgedAged, 80 and overArabsBone DensityFemaleGenetic Association StudiesGenotypeHeterozygoteHumansMiddle AgedOsteoporosisOsteoprotegerinPolymorphism, Single NucleotideRANK LigandOsteoprotegerinRANK LigandTNFRSF11B protein, humanTNFSF11 protein, humanRANKL/OPGrs2073618rs2277438rs3102735rs9533156Saudi postmenopausal womensingle nucleotide polymorphism

Identifiers

PMID33572979
PMCPMC7910965
OpenAlexW3126994402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.